Added value of pharmacogenetic testing in predicting statin response: results from the REGRESS trial
{{output}}
It was investigated whether pharmacogenetic factors, both as single polymorphism and as gene-gene interactions, have an added value over non-genetic factors in predicting statin response. Five common polymorphisms were selected in apolipoprotein E, angiotensin... ...